ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	9/104	30/7206	2.12898369386e-10
ko04060	Cytokine-cytokine receptor interaction	17/104	191/7206	1.40789187787e-09
ko05140	Leishmaniasis	10/104	75/7206	9.62117963865e-08
ko05145	Toxoplasmosis	12/104	126/7206	2.13479318405e-07
ko04659	Th17 cell differentiation	11/104	106/7206	2.94842262837e-07
ko05152	Tuberculosis	14/104	187/7206	3.9731791036e-07
ko05150	Staphylococcus aureus infection	7/104	36/7206	6.30091992208e-07
ko05330	Allograft rejection	6/104	24/7206	8.52237630303e-07
ko04650	Natural killer cell mediated cytotoxicity	10/104	97/7206	1.12192584763e-06
ko04612	Antigen processing and presentation	9/104	77/7206	1.36896278181e-06
ko04660	T cell receptor signaling pathway	11/104	124/7206	1.44613039292e-06
ko05320	Autoimmune thyroid disease	6/104	29/7206	2.83677485905e-06
ko05310	Asthma	5/104	17/7206	3.06544601772e-06
ko04658	Th1 and Th2 cell differentiation	9/104	96/7206	8.76832096958e-06
ko05321	Inflammatory bowel disease (IBD)	7/104	56/7206	1.3818467153e-05
ko04380	Osteoclast differentiation	10/104	134/7206	2.08929170119e-05
ko05164	Influenza A	11/104	167/7206	2.57678240855e-05
ko04640	Hematopoietic cell lineage	7/104	64/7206	3.3677211787e-05
ko05162	Measles	9/104	120/7206	5.30973916877e-05
ko04064	NF-kappa B signaling pathway	8/104	96/7206	6.66865056115e-05
ko04620	Toll-like receptor signaling pathway	8/104	100/7206	8.9242269621e-05
ko05332	Graft-versus-host disease	4/104	18/7206	0.000107236122686
ko04630	Jak-STAT signaling pathway	9/104	132/7206	0.000111640848199
ko04664	Fc epsilon RI signaling pathway	7/104	77/7206	0.000111831208965
ko05416	Viral myocarditis	6/104	55/7206	0.000127789267852
ko04672	Intestinal immune network for IgA production	5/104	37/7206	0.000171681453115
ko05168	Herpes simplex infection	10/104	182/7206	0.000275673911605
ko04145	Phagosome	9/104	162/7206	0.00051971330052
ko04514	Cell adhesion molecules (CAMs)	8/104	130/7206	0.000545597419572
ko04062	Chemokine signaling pathway	10/104	201/7206	0.000607400347894
ko04610	Complement and coagulation cascades	6/104	79/7206	0.000926842417208
ko04940	Type I diabetes mellitus	4/104	32/7206	0.00107903811766
ko04666	Fc gamma R-mediated phagocytosis	7/104	122/7206	0.00183490666299
ko04611	Platelet activation	8/104	163/7206	0.00235932465794
ko05144	Malaria	4/104	45/7206	0.00387377879691
ko04217	Necroptosis	8/104	178/7206	0.0040567429526
ko04670	Leukocyte transendothelial migration	7/104	151/7206	0.00601672263274
ko05322	Systemic lupus erythematosus	7/104	151/7206	0.00601672263274
ko05167	Kaposi's sarcoma-associated herpesvirus infection	8/104	191/7206	0.00618405293114
ko03050	Proteasome	4/104	54/7206	0.00744891583114
ko05133	Pertussis	5/104	87/7206	0.00824468317968
ko04662	B cell receptor signaling pathway	5/104	88/7206	0.00864328319265
ko05323	Rheumatoid arthritis	5/104	89/7206	0.00905505627507
ko05169	Epstein-Barr virus infection	8/104	206/7206	0.00959366659047
ko04621	NOD-like receptor signaling pathway	6/104	157/7206	0.0256464750536
ko00120	Primary bile acid biosynthesis	2/104	20/7206	0.033102010526
ko00590	Arachidonic acid metabolism	3/104	52/7206	0.0387615196101
ko05142	Chagas disease (American trypanosomiasis)	5/104	130/7206	0.0394485900823